[
  {
    "ts": null,
    "headline": "Regeneron to acquire bankrupt genetic tester 23andMe",
    "summary": "Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to boost its drug discovery capabilities using DNA data. Yahoo Finance Senior Reporter Anjalee Khemlani explains how the deal ties into Regeneron’s broader strategy and addresses privacy concerns. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=61c2b9c16df5edeb1a31803072a8b1aa105923ca11f08eb0008f8631ca36876b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747687358,
      "headline": "Regeneron to acquire bankrupt genetic tester 23andMe",
      "id": 134609316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to boost its drug discovery capabilities using DNA data. Yahoo Finance Senior Reporter Anjalee Khemlani explains how the deal ties into Regeneron’s broader strategy and addresses privacy concerns. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=61c2b9c16df5edeb1a31803072a8b1aa105923ca11f08eb0008f8631ca36876b"
    }
  },
  {
    "ts": null,
    "headline": "Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal",
    "summary": "Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its genetics-based drug discovery efforts. The acquisition includes 23andMe’s Personal Genome Service, Total Health, Research Services divisions, its Biobank, and associated infrastructure. Regeneron plans to keep consumer services running without disruption and expects the transaction to close in the thi",
    "url": "https://finnhub.io/api/news?id=b6685a0cac501a9db14cc919eee34b04a9888d1d13b2b68132fa4109be07f7ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747682964,
      "headline": "Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal",
      "id": 134601857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction for key assets of 23andMe Holding Co. in a $256 million deal to boost its genetics-based drug discovery efforts. The acquisition includes 23andMe’s Personal Genome Service, Total Health, Research Services divisions, its Biobank, and associated infrastructure. Regeneron plans to keep consumer services running without disruption and expects the transaction to close in the thi",
      "url": "https://finnhub.io/api/news?id=b6685a0cac501a9db14cc919eee34b04a9888d1d13b2b68132fa4109be07f7ba"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Climbs as UnitedHealth Rebounds - Health Care Roundup",
    "summary": "Health Care Climbs as UnitedHealth Rebounds - Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=0b1fae7f6720250a7ffd61b5a327497baedaad6bcd20d74a3f915ed32d531526",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747674300,
      "headline": "Health Care Climbs as UnitedHealth Rebounds - Health Care Roundup",
      "id": 134612771,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Health Care Climbs as UnitedHealth Rebounds - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=0b1fae7f6720250a7ffd61b5a327497baedaad6bcd20d74a3f915ed32d531526"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Buys 23andMe in Bankruptcy Auction",
    "summary": "Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.",
    "url": "https://finnhub.io/api/news?id=bf23214ffcaf1df7d2851a3882ea1710cf39ed4a7552f3fcd81c02724243b239",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747672922,
      "headline": "Regeneron Buys 23andMe in Bankruptcy Auction",
      "id": 134601858,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals agreed to buy DNA testing company 23andMe in a bankruptcy court auction, the company said Monday.",
      "url": "https://finnhub.io/api/news?id=bf23214ffcaf1df7d2851a3882ea1710cf39ed4a7552f3fcd81c02724243b239"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron buys bankrupt 23andMe for $256m",
    "summary": "The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.",
    "url": "https://finnhub.io/api/news?id=b358e8ddc23747f09afc7f15f222dc40f87f4746c03b4fd864e56d14af568ff6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747671894,
      "headline": "Regeneron buys bankrupt 23andMe for $256m",
      "id": 134601859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.",
      "url": "https://finnhub.io/api/news?id=b358e8ddc23747f09afc7f15f222dc40f87f4746c03b4fd864e56d14af568ff6"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Is Buying 23andMe. The Deal Is a Head-Scratcher.",
    "summary": "Biotech Regeneron already faces enough of its own challenges without taking on a the troubled legacy of genetic-testing firm 23andMe.",
    "url": "https://finnhub.io/api/news?id=e5887ca26bab3cdcdbd5394bff37651982a87cbad1e4d8adcec571c3c9bf23e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747671180,
      "headline": "Regeneron Is Buying 23andMe. The Deal Is a Head-Scratcher.",
      "id": 134601860,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Biotech Regeneron already faces enough of its own challenges without taking on a the troubled legacy of genetic-testing firm 23andMe.",
      "url": "https://finnhub.io/api/news?id=e5887ca26bab3cdcdbd5394bff37651982a87cbad1e4d8adcec571c3c9bf23e0"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron agrees to purchase bankrupt 23andMe, protect data",
    "summary": "The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.",
    "url": "https://finnhub.io/api/news?id=07560571e1206bac584deda0a244d5711e43adad17545096cd99e024a1cd70e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747669881,
      "headline": "Regeneron agrees to purchase bankrupt 23andMe, protect data",
      "id": 134609318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.",
      "url": "https://finnhub.io/api/news?id=07560571e1206bac584deda0a244d5711e43adad17545096cd99e024a1cd70e7"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal",
    "summary": "Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it would buy \"substantially all\" of 23andMe's assets.",
    "url": "https://finnhub.io/api/news?id=4d1f67dc46681906269303ca2f466f8ca63b917bf5173d5952b64790aba2bb03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747669512,
      "headline": "Regeneron Pharmaceuticals to buy bankrupt 23andMe in $256M deal",
      "id": 134601861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection in March. Regeneron Pharmaceuticals announced it would buy \"substantially all\" of 23andMe's assets.",
      "url": "https://finnhub.io/api/news?id=4d1f67dc46681906269303ca2f466f8ca63b917bf5173d5952b64790aba2bb03"
    }
  },
  {
    "ts": null,
    "headline": "23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals",
    "summary": "Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a condition of the sale.",
    "url": "https://finnhub.io/api/news?id=f16df4a884477fb405e10c4fac64a48c8a79cd0ef52289fdd06f7097a3799852",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747668300,
      "headline": "23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals",
      "id": 134628760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a condition of the sale.",
      "url": "https://finnhub.io/api/news?id=f16df4a884477fb405e10c4fac64a48c8a79cd0ef52289fdd06f7097a3799852"
    }
  },
  {
    "ts": null,
    "headline": "23andMe just got bought out of bankruptcy",
    "summary": "23andMe (ME) will have a second life.",
    "url": "https://finnhub.io/api/news?id=afa341bcbcd93e0b66aef018af8f272df5fc5e3d8bab9e1ec88232026f65d7e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747665120,
      "headline": "23andMe just got bought out of bankruptcy",
      "id": 134601862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "23andMe (ME) will have a second life.",
      "url": "https://finnhub.io/api/news?id=afa341bcbcd93e0b66aef018af8f272df5fc5e3d8bab9e1ec88232026f65d7e7"
    }
  },
  {
    "ts": null,
    "headline": "23andMe to be acquired by Regeneron",
    "summary": "Regeneron bids for 23andMe at a discounted price of $256 million. The testing firm was once valued at $3.5 billion.",
    "url": "https://finnhub.io/api/news?id=5c70b3008b6677837155f8fdde5494a5bea9cc54e3271f8f887b9688a378888b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747661931,
      "headline": "23andMe to be acquired by Regeneron",
      "id": 134601863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron bids for 23andMe at a discounted price of $256 million. The testing firm was once valued at $3.5 billion.",
      "url": "https://finnhub.io/api/news?id=5c70b3008b6677837155f8fdde5494a5bea9cc54e3271f8f887b9688a378888b"
    }
  },
  {
    "ts": null,
    "headline": "23andMe sells gene-testing business to DNA drug maker Regeneron",
    "summary": "Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.",
    "url": "https://finnhub.io/api/news?id=9db8650ea3ce994371f7d7e613e30b6f3d17a742b9cd237e5deb5771c9bcf5a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747661589,
      "headline": "23andMe sells gene-testing business to DNA drug maker Regeneron",
      "id": 134601864,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.",
      "url": "https://finnhub.io/api/news?id=9db8650ea3ce994371f7d7e613e30b6f3d17a742b9cd237e5deb5771c9bcf5a2"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals to Acquire 23andMe for $256M",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced today that it will acquire 23andMe for a purchase price of $256 million. 23andMe had filed for bankruptcy protection in March this year, while REGN was the sole bidder for its assets. REGN intends to acquire its Personal Genome Service, Total Health, and Research Services business line, together with its Biobank […]",
    "url": "https://finnhub.io/api/news?id=6627484d376051119eeda8356637318c5c1e40a9ca5dbb8c14e0bf6bdfdc9433",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747661313,
      "headline": "Regeneron Pharmaceuticals to Acquire 23andMe for $256M",
      "id": 134601865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced today that it will acquire 23andMe for a purchase price of $256 million. 23andMe had filed for bankruptcy protection in March this year, while REGN was the sole bidder for its assets. REGN intends to acquire its Personal Genome Service, Total Health, and Research Services business line, together with its Biobank […]",
      "url": "https://finnhub.io/api/news?id=6627484d376051119eeda8356637318c5c1e40a9ca5dbb8c14e0bf6bdfdc9433"
    }
  },
  {
    "ts": null,
    "headline": "Biotechnology company Regeneron buying 23andMe for $256 million",
    "summary": "Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.  In March 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.  Its co-founder and CEO Anne Wojcicki also resigned from the top post, but remained as a board member.",
    "url": "https://finnhub.io/api/news?id=8afa536343c2d22a598e8bf7413dd3fe2665589c9c25a6c9f3ddfe29469af29e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747659633,
      "headline": "Biotechnology company Regeneron buying 23andMe for $256 million",
      "id": 134601866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.  In March 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.  Its co-founder and CEO Anne Wojcicki also resigned from the top post, but remained as a board member.",
      "url": "https://finnhub.io/api/news?id=8afa536343c2d22a598e8bf7413dd3fe2665589c9c25a6c9f3ddfe29469af29e"
    }
  },
  {
    "ts": null,
    "headline": "23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction",
    "summary": "Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.",
    "url": "https://finnhub.io/api/news?id=c5f033338b9c3bdec5315cdfbc54cefb29649da86dfa01f7ea35a88871241271",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747659330,
      "headline": "23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction",
      "id": 134601867,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.",
      "url": "https://finnhub.io/api/news?id=c5f033338b9c3bdec5315cdfbc54cefb29649da86dfa01f7ea35a88871241271"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million",
    "summary": "Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.",
    "url": "https://finnhub.io/api/news?id=171271732440bd07a9a073a81f0fbe2cefce43cf916125b884807b6c0a8e108b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747657294,
      "headline": "Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million",
      "id": 134601868,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.",
      "url": "https://finnhub.io/api/news?id=171271732440bd07a9a073a81f0fbe2cefce43cf916125b884807b6c0a8e108b"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million",
    "summary": "Regeneron Pharmaceuticals said it will acquire substantially all assets of the once-sizzling DNA-testing startup.",
    "url": "https://finnhub.io/api/news?id=14f29c0a38fa553b8f264d9b54aa2daa821e1f2828cef923bba0e9865b7f7bc9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747655280,
      "headline": "Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million",
      "id": 134577501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals said it will acquire substantially all assets of the once-sizzling DNA-testing startup.",
      "url": "https://finnhub.io/api/news?id=14f29c0a38fa553b8f264d9b54aa2daa821e1f2828cef923bba0e9865b7f7bc9"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness",
    "summary": "Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court-appointed Customer Privacy Ombudsman Planned purchase to strengthen Regeneron’s ongoing leadership in genetics-guided research and drug development to help people with serious diseases TARRYTOWN, N.Y., May 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced",
    "url": "https://finnhub.io/api/news?id=0ac91330a68450b2093327f958d7ba950cb7c1796268f45e44b229e24b2ed3b9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747652820,
      "headline": "Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness",
      "id": 134577503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Purchase is subject to bankruptcy court and regulatory approvals Regeneron will prioritize the privacy, security and ethical use of 23andMe’s customer data; stands ready to work with independent, court-appointed Customer Privacy Ombudsman Planned purchase to strengthen Regeneron’s ongoing leadership in genetics-guided research and drug development to help people with serious diseases TARRYTOWN, N.Y., May 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced",
      "url": "https://finnhub.io/api/news?id=0ac91330a68450b2093327f958d7ba950cb7c1796268f45e44b229e24b2ed3b9"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale",
    "summary": "Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement for the sale of 23andMe to Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN",
    "url": "https://finnhub.io/api/news?id=53ef222d9a93945d4d6a661c0ca907e5c6a28eb0d22bbd26d9910f01bb631f23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747652640,
      "headline": "Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale",
      "id": 134577504,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered into a definitive agreement for the sale of 23andMe to Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN",
      "url": "https://finnhub.io/api/news?id=53ef222d9a93945d4d6a661c0ca907e5c6a28eb0d22bbd26d9910f01bb631f23"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron wins bid to buy 23andMe out of bankruptcy",
    "summary": "The biotech, which has for years invested in genetics research, plans to acquire \"substantially all\" of testing firm 23andMe's assets for $256 million.",
    "url": "https://finnhub.io/api/news?id=336812a9ea42b465097b4fc6c8af921874a99465ecdf0766b8bdf93f1d9c88b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747652400,
      "headline": "Regeneron wins bid to buy 23andMe out of bankruptcy",
      "id": 134601869,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The biotech, which has for years invested in genetics research, plans to acquire \"substantially all\" of testing firm 23andMe's assets for $256 million.",
      "url": "https://finnhub.io/api/news?id=336812a9ea42b465097b4fc6c8af921874a99465ecdf0766b8bdf93f1d9c88b8"
    }
  },
  {
    "ts": null,
    "headline": "23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private",
    "summary": "23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private",
    "url": "https://finnhub.io/api/news?id=7e3221a4d3fddb92dc3441a3d5c30723f746389fa3ce328d957b34655529895b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747649820,
      "headline": "23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private",
      "id": 134590755,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private",
      "url": "https://finnhub.io/api/news?id=7e3221a4d3fddb92dc3441a3d5c30723f746389fa3ce328d957b34655529895b"
    }
  }
]